Current therapies in ovarian cancer.
Fields
Abbie L
AL
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women's Health, Albert Einstein College of Medicine, Montefiore Medical Center, 1695 Eastchester Road, Suite 601, Bronx, NY 10461, USA. afields@montefiore.org
Runowicz
Carolyn D
CD
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D017277:Drug Approval; D005260:Female; D005544:Forecasting; D006801:Humans; D007262:Infusions, Intravenous; D007274:Injections, Intraperitoneal; D015337:Multicenter Studies as Topic; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D017239:Paclitaxel / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D016879:Salvage Therapy; D019772:Topotecan / Q000008:administration & dosage; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D009944:Organoplatinum Compounds; D019772:Topotecan; D004317:Doxorubicin; D017239:Paclitaxel